Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Comment by Pareto8020on Nov 09, 2020 7:33pm
168 Views
Post# 31867759

RE:RE:RE:RE:Breakaway gap at 30 cents cdn now closed

RE:RE:RE:RE:Breakaway gap at 30 cents cdn now closedSBM definitely has the goods but between Howard trying to figure things out as he goes and lack of a viable promotions company to get the SBM story out to investors it has been years of treading water.  

They've been stumbling their way with the skin lightener for so long it is really unbelievalbe.  They could have completed both the clinical trials and had this to market years ago if the CEO had laid out the proper path to take to get this to market.  Instead the CEO is using consultants and figuring out the best route to take by trial and error which isn't the most optimum method to build a successful company.  If it wasn't for Geraldines' tech this play would be a drift and worth mere pennies by now.      
Bullboard Posts